![Stephen Doberstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Doberstein
Directeur/Membre du Conseil chez
Invea Therapeutics, Inc.
Profil
Dr. Stephen K.
Doberstein is an Independent Director at Invea Therapeutics, Inc. and a Principal at Kahiliholo Consulting LLC.
He is on the Board of Directors at Invea Therapeutics, Inc. Dr. Doberstein was previously employed as an Independent Director by Forte Biosciences, Inc., an Independent Director by Dicerna Pharmaceuticals, Inc., a Chief Scientific Fellow & Senior Vice President by Nektar Therapeutics, a Vice President-Research by XOMA Royalty Corp., a Vice President-Research by Five Prime Therapeutics, Inc., a Vice President-Research by Xencor, Inc., a Director-Pharmaceutical Target Research by Exelixis, Inc., and an Engineer by EIDP, Inc. He also served on the board at Parmedics, Inc. He received his undergraduate degree from the University of Delaware and a doctorate degree from The Johns Hopkins University School of Medicine.
Postes actifs de Stephen Doberstein
| Sociétés | Poste | Début |
|---|---|---|
Kahiliholo Consulting LLC | Corporate Officer/Principal | 01/02/2020 |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Directeur/Membre du Conseil | 01/12/2024 |
Anciens postes connus de Stephen Doberstein
| Sociétés | Poste | Fin |
|---|---|---|
| FORTE BIOSCIENCES | Directeur/Membre du Conseil | 27/08/2026 |
| DICERNA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/12/2021 |
| NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/03/2020 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2008 |
| XENCOR, INC. | Directeur Technique/Scientifique/R&D | 01/07/2004 |
Formation de Stephen Doberstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Health Technology |
Kahiliholo Consulting LLC |
